Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin

Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment

(2015) Navjotsingh Pabla et al.   Oncotarget

G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

(2013) Danielle M. Hsu et al.   CANCER RESEARCH

Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential

(2012) Verline Justilien et al.   PLoS One

Probenecid is a chemosensitizer in cancer cell lines

(2011) Denise Campos-Arroyo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils

(2011) Davide Torti et al.   EMBO Molecular Medicine

High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition

(2010) Ola Awad et al.   PLoS One

Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies

(2010) Chung-Pu Wu et al.   Current Molecular Pharmacology

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

(2008) Andrew DJ Pearson et al.   LANCET ONCOLOGY